JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishiki, K.
Right arrow Articles by Fujimura, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishiki, K.
Right arrow Articles by Fujimura, A.

GASTROINTESTINAL, HEPATIC, PULMONARY, AND RENAL

Inhibition of Rho-Kinase Reduces Renal Na-H Exchanger Activity and Causes Natriuresis in Rat

Kenta Nishiki, Shuichi Tsuruoka, Atsuhiro Kawaguchi, Kohichi Sugimoto, George J. Schwartz, Makoto Suzuki, Masashi Imai, and Akio Fujimura

From Departments of Clinical Pharmacology (K.N., S.T., A.K., K.S., A.F.) and Pharmacology (M.S., M.I.), Jichi Medical School, Minamikawachi, Tochigi, Japan; and Department of Pediatrics (G.J.S.), University of Rochester School of Medicine and Dentistry, Rochester, New York

Received July 18, 2002; accepted October 22, 2002.


    Abstract
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Rho-kinase regulates the actin cytoskeleton and therefore modulates transport. The role of Rho-kinase in Na-H exchanger (NHE) activity of rat proximal convoluted tubules (PCTs) was investigated using (R)-(+)-trans-N-(4-pyridyl)-4-(1-aminoethyl)-cyclohexanecarboxamide (Y-27632), a specific inhibitor of Rho-kinase. In spontaneously hypertensive rats (SHR) and Wistar Kyoto (WKY) rats, apical and basolateral NHE activities were determined by measuring cell pH recovery following luminal prepulse and basolateral sodium removal, respectively. Apical NHE activity was greater in 8 to 9 week old hypertensive SHR compared with WKY. Although Y-27632 suppressed pHi recovery in both strains, sensitivity was 50-fold higher in adult SHR. Y-27632 suppressed basolateral NHE in both strains with similar sensitivity. Apical NHE activity was not greater in 5-week-old, not yet hypertensive, SHR rats compared with WKY. In clearance studies, Na excretion was less in SHR than in WKY rats. Y-27632 increased Na excretion and fractional excretion Na in both strains but more so in SHR. 22Na uptake of the brush border membrane vesicle taken from Y-27632-treated rats decreased more than that from vehicle-treated animals in both adult SHR and WKY. We conclude that apical NHE activity is increased in SHR PCT compared with controls and that inhibition of Rho-kinase reduces PCT NHE activities and causes natriuresis.


Renal tubular sodium reabsorption is crucial to maintain an effective circulating volume and blood pressure (Rose, 1994Go). Under physiological conditions, sodium-hydrogen exchanger isoform 3 (NHE3) in the apical membrane of the proximal tubule cell is one of the major transporters involved in renal sodium reabsorption (Alpern and Rector, 1996Go). Renal sodium uptake is enhanced in patients with essential hypertension as well as in some hypertensive animal models (Kaplan, 1998Go). NHE3 activity is up-regulated in the spontaneously hypertensive rat (SHR), an animal model of hypertension (Hayashi et al., 1997Go).

The state of the cytoskeleton situated beneath the cell membrane can modulate activities of sodium transporters located on the membrane (Mills et al., 1994Go; Hamm-Alvarez and Sheetz, 1998Go). Shrinkage of the cell increases NHE activity in astrocytes by modulating myosin light chain kinase (Shrode et al., 1995Go). The state of actin organization modulates trafficking of NHE3 protein and thereby changes its activity in renal proximal tubular cells (Chalumeau et al., 2001Go). Furthermore, Kurashima et al. (1999Go) reported using CHO cells transfected with NHE3 and that the NHE3 requires an intact actin cytoskeleton to maintain its usual function.

Small GTP-binding proteins of Rho family (Rho, Rac, and Cdc40) are among the regulators of the actin cytoskeleton (Hall, 1998Go). Systemic inhibition of p160ROCK (a Rho-associated coil-forming protein kinase) (Hirata et al., 1992Go) by administration of a selective inhibitor, Y-27632, lowers blood pressure by the disruption of the cytoskeleton and inhibition of NHE1 activity in vascular smooth muscle cells, leading to the reduction in arterial resistance (Uehata et al., 1997Go). We have recently reported in neutrophils that Y-27632 inhibited superoxide anion production (Kawaguchi et al., 2000Go). Furthermore, myosin light chain phosphorylation by Rho-kinase is a prerequisite for normal NHE3 function in transfected CHO cells (Szaszi et al., 2000Go). Thus, it is possible that NHE may play a significant role in modulating blood pressure via Rho-kinase mediated mechanisms. It remains to be determined, however, whether the Rho-kinase actually affects intact NHE3 in native renal tubular cells and subsequent Na/fluid balance in the body.

The purpose of this study was as follows: 1) to examine the contribution of p160ROCK to maintaining NHE3 and NHE1 activities in rat isolated perfused proximal convoluted tubule cells in vitro by using a selective inhibitor Y-27632; 2) to compare this contribution in young (not yet hypertensive) (Yamori, 1974Go) and adult (hypertensive) rats; 3) to determine the effect of Y-27632 on urine volume and sodium excretion by an in vivo clearance study; and finally 4) to compare the roles of inhibiting p160ROCK in SHR versus control animals.


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Animals. Male Wistar Kyoto (WKY) rats and spontaneously hypertensive rats (SHR/Izm) were purchased from Funabashi No-en (Funabashi, Chiba, Japan). Systolic arterial blood pressure (BP) was measured by a tail-cuff method. For microperfusion, we selected five (young; developing phase of hypertension) (Yamori, 1974Go) and eight- to nine-week-old rats (adult; established phase of hypertension). The clearance study was performed using 8- to 9-week-old animals because of technical difficulties of cannulation to femoral veins in young rats. The number of animals was 10 and 20 in young and adult WKY rats, respectively, and 9 and 22 in young and adult SHR, respectively. All animals were allowed free access to standard rat chow (CE-2; Japan Clea Co. Ltd., Tokyo, Japan) and tap distilled water until the initiation of the experiments. This study was conducted in accordance with the Guideline for Animal Research at Jichi Medical School.

In Vitro Microperfusion. In vitro perfusion of isolated proximal convoluted (S1) tubule was performed in accordance with Burg et al. (1966Go), as modified in our laboratory (Tsuruoka et al., 2000Go, 2001Go). In brief, animals were anesthetized with intraperitoneal injection of pentobarbital sodium. The left kidney was removed and coronal slices were made. The slices were transferred to a chilled solution of the following composition: 14 mM KH2PO4, 44 mM K2HPO4, 15 mM KCl, 9 mM NaHCO3, and 160 mM sucrose with pH 7.4. S1 segments with length ranging from 0.25 to 0.35 mm were dissected from the superficial labyrinth by fine forceps under stereomicroscope at 4°C. We dissected and used three to eight proximal tubules from each animal. Isolated tubules were transferred to a perfusion chamber mounted on an inverted microscope and perfused in vitro at 37°C. Tubules were hooked up to the holding pipette, and a single-barreled perfusion pipette was inserted into the tubular lumen. Triple-barreled polyethylene tubing was inserted into the perfusion pipette to allow rapid exchange of the perfusion fluid. The perfusion rate was controlled at 10 to 20 nl/min by adjusting the height of the fluid reservoir, which was connected to the back-end of the perfusion pipette. A flow-through bath system was used to allow rapid exchange of bathing fluid. The bath fluid was maintained at 37°C. The flow rate of bath fluid was 3 to 5 ml/min, which allowed the bath fluid to be exchanged within 2 s. The composition of the bicarbonate-free solution for perfusing and bathing solutions in this study was as follows: 135 mM NaCl, 5 mM KCl, 1.6 mM Na2HPO4, 0.4 mM NaH2PO4, 1.8 mM CaCl2, 1 mM MgCl2, 10 mM HEPES, 5.6 mM glucose, and 5 mM L-alanine at pH 7.4 and 293 ± 3 mOsm/kg. For the prepulse solution, 40 mM NaCl of the bicarbonate-free solution was replaced by NH4Cl.

Measurement of Intracellular pH. Acetoxymethyl ester of 2',7'-bis(carboxyethyl) carboxyfluorescein (BCECF-AM) was used as an indicator of intracellular pH (pHi). BCECF-AM was added to the bicarbonate-free solution from a stock solution (1 mM in dimethyl sulfoxide) to a final concentration of 1 µM. After the microperfused tubule was stabilized for 15 min, BCECF-AM was added to the bathing solution, and the tubules were incubated for about 20 min. Then, BCECF was removed from the bathing solution, and the experiments were started.

Measurement of intracellular pH was performed by a fluorescence ratio imaging technique using an Olympus OSP system (Olympus Optical, Tokyo, Japan), as described previously (Tsuruoka et al., 1993Go, 2001Go). Measurements were done at 400x magnification; the diameter of the beam of light focused on the tubule was 25 µm. BCECF fluorescence was measured at an emission wavelength of 530 nm in response to excitation wavelengths of 490 and 440 nm. Autofluorescence-corrected fluorescence ratio values (490/440 nm) were calculated by the apparatus every 1 s. We used only the tubules showing at least 20-fold greater intensity than that of background. To minimize photobleaching and cell damage, the duration of each experiment was made as short as possible. BCECF fluorescence was calibrated using the nigericin/high K method, and fluorescence ratios were converted to pH units, as described previously (Thomas et al., 1979Go).

Measurement of Apical and Basolateral NHE Activities. Apical NHE activity of the cell was assessed by the H-ATPase-independent pHi recovery rate (dpHi/dt) after intracellular acid loading in basal bicarbonate-free solution under the luminal presence of 5 nM bafilomycin A1, a specific inhibitor of the vacuolar H-ATPase (Dagher and Sauterey, 1992Go; Tsuruoka and Schwartz, 1997Go). The acid load was accomplished by the prepulse; after 5 min of exposure to 40 mM NH4Cl, the ammonium was rapidly removed. The initial rate of recovery (dpHi/dt) at around pHi 7.0 was used for the evaluation (Fig. 1). To calculate the initial dpHi/dt, a regression line was obtained using StatView software (SAS Institute, Inc., Cary NC). We monitored dpHi/dt for more than 7 min after the pulse to determine the initial slope. From the increase in pHi over 50 s, the initial slope was calculated. It took approximately 45 min from initiation of the perfusion to termination of the pHi monitoring.



View larger version (23K):
[in this window]
[in a new window]
 
Fig. 1. Representative tracings of cell pH (pHi) following ammonium prepulse (40 mM NH4Cl to lumen) and effect of Y-27632 (107 M) in rat proximal tubule cell. Apical NHE activity was estimated by slope of pHi change (dpHi/dt; dashed line) just after removal of ammonium from tubular lumen. A and B, adult WKY; C and D; adult SHR.

 

Preliminary studies confirmed that the bafilomycin A1-insensitive pHi recovery was completely abolished by concomitant addition of amiloride (1 mM) to lumen, which was previously used for the evaluation of the activity (Hayashi et al., 1997Go). Thus, the bafilomycin A1-insensitive pHi recovery was comparable to the amiloride-inhibitable pHi recovery after the prepulse. Vehicle (water) or a concentration of Y-27632 was added with bafilomycin A1 10 min before the initiation of the prepulse.

Basolateral NHE activity was determined by the change of pHi following the removal of Na from bathing solution (Geibel et al., 1989Go). The pHi stabilized within 3 min after this maneuver. We have previously confirmed that this change of pHi was completely abolished by concomitant addition of amiloride (10 µM) to the bath (Tsuruoka et al., 1993Go). During these experiments we perfused with a Na-free solution for the time that Na was removed from the basolateral solution (Hayashi et al., 1997Go).

In Vivo Clearance Study. The in vivo clearance study was performed as reported by Kawaguchi et al. (2001Go) from our laboratory. In brief, the animals were anesthetized using Inactin (BYK Gulden, Konstanz, Germany; 100 mg/kg, i.p.) and a tracheostomy performed. The femoral artery was cannulated with PE-10 tubing, which was connected to PE-50 tubing for blood sampling and blood pressure monitoring under anesthesia. The femoral vein was cannulated for infusion of medications and agents. Thereafter, bladder puncture was performed by insertion of PE-50 tubing after urethral ligation; animals with gross hematuria were discarded. Inulin (0.5% in saline) was continuously infused at 55 µl/min. After an equilibration period of 90 min, urine was collected during two successive 60-min periods (from 90 to 150 min and 210 to 270 min). The first period was considered the control period and the second period as the experimental one. This latter period began just after the first urinary collection (150 min) with a continuous infusion of Y-27632 (0.8 mg/kg/h; generous gift from Yoshitomi Pharmaceutical Co. Ltd., Osaka, Japan) or vehicle. The infusion continued until the end of the study (270 min). In preliminary studies, we found that this infusion rate of Y-27632 was the maximum dose that could be given without a reduction in systemic blood pressure. We carefully monitored mean arterial blood pressure during the study, and an experiment was discarded when the mean blood pressure decreased more than 5% of the basal level. Blood sampling (200 µl) was performed at the midpoint of each urine collection period; an equal volume of saline was injected to offset the loss of blood. Concentrations of inulin, Na, K, and creatinine were measured from both urine and serum specimens. Inulin concentration was determined by modified anthrone method and concentrations of Na and K were measured by an Auto-Analyzer. Data for urinary sodium excretion (milliequivalent per hour per 100 g b.wt.), fractional excretion of sodium and potassium (FE Na and FE K, in percentages), and GFR (milliliter per minute per 100 g b.wt.) were generated from standard calculations.

22Na Uptake Study with Brush-Border Membrane Vesicle. Brush-border membrane vesicle (BBMV) was prepared from the renal cortex of adult WKY and SHR. 22Na uptake studies were performed according to Morduchowicz et al. (1989Go). In brief, purified BBMV were prepared by Mg2+ precipitation method from SHR and WKY treated with Y-27632 or vehicle in vivo. The way of treatment was similar with in vivo clearance study mentioned above. Transport study using 22Na was performed at room temperature by a Millipore rapid-filtration procedure. 22Na uptake was measured in the presence of an outward H+ gradient induced by preincubation of medium (273 mM mannitol, 10 mM MgSO4, 9 mM Tris, 14 mM HEPES, and 30 mM MES, pH 6.0). Uptake was initiated by incubation of vesicles with medium (1 mM 22NaCl, 286 mM mannitol, 2 mM MgSO4, 13 mM Tris, 15 mM HEPES, 6 mM MES, pH 7.5) and was stopped on ice-cold isosmotic solution. The uptake was increased with time until 30 s. To evaluate initial uptake rate, we measured the uptake at 5 and 15 s after initiation of the incubation. Protein concentration was measured by Coomassie brilliant blue with bovine serum albumin as the reference protein. The initial 22Na uptake rate was expressed in moles per milligram protein per 5 s (Morduchowicz et al., 1989Go).

Statistical Analysis. Data are expressed as the mean ± S.E. Statistical analysis was performed by two-way analysis of variance and repeated measures approach when necessary. Significance was asserted when P < 0.05.


    Results
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
Mean Blood Pressure Is Higher in SHR than in WKY Rats. Systolic BP was 112 ± 4 and 110 ± 5 mm Hg in young (n = 10) and adult (n = 20), WKY rats, respectively, and 138 ± 10 and 158 ± 6 mm Hg in young (n = 9) and adult (n = 22) SHR, respectively. The systolic BP values in the SHR rats were significantly higher than those in the WKY rats at both age groups (P < 0.05). The BP in young SHR was significantly lower than adult SHR.

Apical NHE Activity Is Reduced by the Inhibition of Rho-Kinase Activity. Figure 1A shows a representative tracing of pHi recovery before and after the prepulse, during which bafilomycin A1 was present in the perfusate, in proximal convoluted tubule cells of adult WKY rats. The pHi under basal conditions was 7.33 ± 0.03 pH units (n = 82 cells). After the prepulse, the pHi decreased to ~7.0 and rapidly recovered. The dpHi/dt was 60 ± 8 x 102 pH units/s (n = 8; Fig. 2A, vehicle). Treatment with 107 M Y-27632 significantly reduced dpHi/dt recovery from the acid load (Fig. 1B), and this was evident in a concentration-dependent manner (Fig. 2A). The mean value at 1 x 106 M was 10 ± 8 x 102 pH units/s (n = 7; Fig. 2A). Figure 2B shows a 75% reduction of apical Na-H activity at 107 M.



View larger version (21K):
[in this window]
[in a new window]
 
Fig. 2. Effect of Y-27632 on apical Na-H activity in SHR and WKY. A, change of dpHi/dt after apical NH4 prepulse in adult (established hypertension) SHR and WKY; B, change of dpHi/dt after apical NH4 prepulse in young (developing phase of hypertension) SHR and WKY; C, percent reduction of apical NHE activity compared with vehicle in adult and young SHR and WKY.

 

In proximal convoluted tubule cells from SHR, the pHi recovery was significantly greater than that in the age-matched WKY (a representative tracing is shown in Fig. 1C). The mean value for dpHi/dt was 95 ± 15 x 102 pH units/s (n = 70). Y-27632 also significantly suppressed the dpHi/dt (Fig. 1D) in a concentration-dependent manner in SHR (Fig. 2A), and the sensitivity to the drug as determined by the 50% reduction (percent reduction) was about 50-fold greater than that in WKY (Fig. 2B).

We evaluated pHi recovery in proximal tubule cells of young SHR and WKY rats. Basal dpHi/dt was 59 ± 10 x 102 and 42 ± 10 x 102 pH units/s in SHR and WKY, respectively, and there was no significant difference between the two groups (P = 0.08, n = 60; Fig. 2C). Treatment with Y-27638 significantly reduced pHi recovery in a concentration-dependent manner in both groups (Fig. 2C). The sensitivity to the drug in young SHR was similar to that in young WKY rats (Fig. 2C).

Basolateral NHE Activity Is Suppressed by the Inhibition of Rho-Kinase Activity. Removal of Na from bath-induced pHi recovery to the same extent in proximal tubules from adult WKY rats (0.34 ± 0.05 pH units, n = 21) and SHR (0.36 ± 0.06 pH units, n = 22). Pretreatment with Y-27632 significantly suppressed the change of pHi in a concentration-dependent manner (Fig. 3). The sensitivity of the two groups did not differ significantly. In young animals, the recovery of pHi after Na removal and the sensitivity to Y-27632 were similar to those of adult rats (Fig. 3).



View larger version (20K):
[in this window]
[in a new window]
 
Fig. 3. Effect of Y-27632 on basolateral Na-H activity in adult and young SHR and WKY.

 

Y-27632 Increases Sodium Excretion and Urinary Volume at a Subdepressor Dose. In WKY rats, the systemic infusion of Y-27632 at a subdepressor dose significantly increased urinary volume, urinary Na excretion, and FE Na, whereas GFR and FE K were not influenced (Table 1). Vehicle alone did not change any parameters. In SHR, urine volume at basal condition was not different from that in WKY. Basal FE Na in SHR was significantly lower than that of WKY rat (0.26 ± 0.06 versus 0.40 ± 0.05%, P = 0.04), but total Na excretion during control period was not significantly lower than that in WKY rat (0.034 ± 0.009 versus 0.052 ± 0.007 mEq/h/100 g b.wt., P = 0.08). After the addition of Y-27632, urinary volume, Na excretion, and FE Na significantly increased in both groups of rats (Table 1). The changes of Na excretion and FE Na were greater in SHR, whereas the change of urinary volume of the two groups did not differ significantly. There were no changes in FE K induced by Y-27632. Mean arterial pressure during the experiments is listed in Table 1. Although mean arterial pressure in SHR was significantly higher than that in age-matched WKY rats, it was not changed by Y-27632 treatment in either group.


View this table:
[in this window]
[in a new window]
 
TABLE 1 Effect of Y-27632 (0.8 mg/kg/h) on urine volume, GFR excretion of sodium, and potassium, and blood pressure during the clearance study in adult rats

 

22Na Uptake of BBMV Was Decreased by Treatment of Y-27632. 22Na uptake of BBMV treated with vehicle was significantly higher in adult SHR than age-matched WKY (0.72 ± 0.24 and 1.37 ± 0.30 nmol/mg/5 s, WKY and SHR, respectively; n = 4 each, P < 0.05). In BBMV treated with Y-27632 in vivo, the uptake was significantly (P < 0.05) lower than that treated with vehicle (0.46 ± 0.19 and 0.59 ± 0.27 nmol/mg/5 s, WKY and SHR, respectively; n = 4 in each). In young animals, the uptake was not significantly different between SHR and WKY (0.60 ± 0.14 and 0.55 ± 0.18 nmol/mg/5 s, WKY and SHR, respectively; n = 4 in each). Y-27632 inhibited the uptake to a similar extent in both groups (0.43 ± 0.15 and 0.41 ± 0.12 nmol/mg/5 s, WKY and SHR, respectively; n = 4 each). These results further supported our data with in vitro microperfusion that apical NHE activity was reduced by inhibition of Rho-kinase.


    Discussion
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 
In this study, we found that in vitro pretreatment with Y-27632 reduced NHE activities in both apical (presumably NHE3) and basolateral (presumably NHE1) membranes of rat renal proximal convoluted tubule cells. These findings are compatible with previous results concerning NHE1 in smooth muscle cells and NHE3 in transfected CHO cells (Szaszi et al., 2000Go); however, we are not aware of any published studies concerning the effect of Y-27632 on these transporters in the intact kidney, one of the major organs that expresses NHE3 (Orlowski et al., 1992Go). Because Rho is one of the regulators of the actin cytoskeleton in cell membranes (Hall, 1998Go), the suppression of NHE activity by the drug observed in this study may be mediated by an alteration of the cytoskeletal network in the proximal tubule cells. Indeed, NHE3 activity can be reduced by the disruption of actin with colchicine and cytochalasin D in rat proximal tubule (Chalumeau et al., 2001Go).

We also compared the renal NHE activities in SHR with those in WKY rats. Compared with proximal tubules from WKY rats, there was increased NHE3 activity in tubules from SHR. These findings are compatible with previous results; Morduchowicz et al., 1989Go; Dagher and Sauterey, 1992Go; Hayashi et al., 1997Go). Furthermore, we showed that the sensitivity of the enhanced NHE3 activity in proximal tubules was about 50-fold higher in SHR compared with WKY rats. Because NHE3 mRNA expression is not different between SHR and WKY kidneys (Hayashi et al., 1997Go), the higher NHE3 activity in proximal tubules of SHR may be attributable to the special conditions of anchoring NHE3 to the apical membrane by the actin cytoskeleton of SHR. In aortic endothelium, stress fiber expression was more prominent in SHR than in WKY (White and Fujiwara, 1986Go). This may also be true in renal cells. Further studies, such as the evaluation of p160ROCK expression, are needed to address these differences.

It has also been reported that dpHi/dt after prepulse is mediated largely by NHE activity, but also by vacuolar H-ATPase activity in the apical membrane of proximal convoluted tubules (Dagher and Sauterey, 1992Go; Aldred et al., 2000Go). For this reason, we preincubated proximal tubules with luminal bafilomycin A1, a specific inhibitor of the vacuolar H-ATPase (Tsuruoka and Schwartz, 1997Go), so that only sodium-dependent changes in pHi were evaluated after acid loading the tubules.

Another important finding of this study is that administration of Y-27632 using a subdepressor dose enhanced Na excretion and total urine volume. These clearance results are compatible with the data obtained from our in vitro microperfusion study. Systemic infusion of this drug at a higher dose reduces arterial blood pressure by inhibiting NHE1 in vascular smooth muscle cell (Hirata et al., 1992Go; Uehata et al., 1997Go), which leads to a reduction of renal blood flow and subsequent increase in Na absorption and decrease in urine volume. To evaluate a more specific renal tubular response to this drug, we titrated its dose such that there was no change in blood pressure; under these conditions, we performed the renal clearance study. In general, a natriuresis, especially in patients with hypertension, reduces the blood pressure. Our findings suggest that the natriuresis induced by Y-27632 may contribute to the blood pressure lowering effect of this agent. Although the exact site of action of the drug in the kidney is uncertain, the proximal tubule may be one of the sites because the drug did not change urinary K excretion. We also found that urinary Na excretion induced by Y-27632 via the inhibition of Rho-kinase is more prominent in SHR than in WKY rats. This is in good agreement with our in vitro findings herein. Increases in FE Na and total Na excretion were higher in SHR, whereas changes in urine volume were similar in both strains. Basal FE Na was lower in SHR, which is compatible with previous results (Khraibi and Knox, 1989Go).

In conclusion, we have found that the inhibition of Rho-kinase (which may lead to the disruption of the actin cytoskeleton) reduced the activity of NHE in both apical and basolateral membranes of the native rat renal proximal convoluted tubule. The sensitivity in vitro was higher in adult SHR than in WKY, whereas such a difference was not observed in young animals. In vivo infusion of Y-27632 at a subdepressor dose enhanced urinary volume and Na excretion without affecting the GFR in both strains. The natriuresis was more prominent in SHR than in WKY rats. Thus, the normal actin network in renal proximal convoluted tubule cells is required to maintain NHE activity and urinary Na excretion. The network may be altered in SHR, thereby contributing to salt retention and hypertension. These findings may provide new clues toward better understanding the mechanisms of essential hypertension.


    Acknowledgements
 
We thank Mariko Hojo for technical assistance.


    Footnotes
 
DOI: 10.1124/jpet.102.041871.

ABBREVIATIONS: NHE, sodium-hydrogen exchanger; SHR, spontaneously hypertensive rat; Y-27632, (R)-(+)-trans-N-(4-pyridyl)-4-(1-amino-ethyl)-cyclohexanecarboxamide; WKY, Wistar Kyoto; BP, blood pressure; BCECF-AM, acetoxymethyl ester of 2',7'-bis(carboxyethyl) carboxyfluorescein; FE, fractional excretion; GFR, glomerular filtration rate; BBMV, brush-border membrane vesicle; MES, 4-morpholineethanesulfonic acid; CHO, Chinese hamster ovary.

Address correspondence to: Dr. Shuichi Tsuruoka, Department of Clinical Pharmacology, Jichi Medical School, 3311 Yakushiji, Minamikawachi, Kawachi, Tochigi 329-0498, Japan. E-mail: tsuru{at}jichi.ac.jp


    References
 Top
 Abstract
 Materials and Methods
 Results
 Discussion
 References
 

Aldred KL, Harris PJ, and Eitle E (2000) Increased proximal tubule NHE-3 and H+-ATPase activities in spontaneously hypertensive rats. J Hypertens 18: 623–628.[Medline]

Alpern R and Rector F (1996) Renal acidification mechanisms, in Brenner and Rector's the Kidney (Brenner B ed) pp 408–471, WB Saunders, Philadelphia.

Burg M, Grantham J, Abramow M, and Orloff J (1966) Preparation and study of fragments of single rabbit nephrons. Am J Physiol 210: 1293–1298.[Free Full Text]

Chalumeau C, du Cheyron D, Defontaine N, Kellermann O, Paillard M, and Poggioli J (2001) NHE3 activity and trafficking depend on the state of actin organization in proximal tubule. Am J Physiol Renal Physiol 280: F283–F290.[Abstract/Free Full Text]

Dagher G and Sauterey C (1992) H+ pump and Na+-H+ exchange in isolated single proximal tubules of spontaneously hypertensive rats. J Hypertens 10: 969–978.[Medline]

Geibel J, Giebisch G, and Boron WF (1989) Basolateral sodium-coupled acid-base transport mechanisms of the rabbit proximal tubule. Am J Physiol 257: F790–F797.

Hall A (1998) Rho GTPases and the actin cytoskeleton. Science (Wash DC) 279: 509–514.[Abstract/Free Full Text]

Hamm-Alvarez SF and Sheetz MP (1998) Microtubule-dependent vesicle transport: modulation of channel and transporter activity in liver and kidney. Physiol Rev 78: 1109–1129.[Abstract/Free Full Text]

Hayashi M, Yoshida T, Monkawa T, Yamaji Y, Sato S, and Saruta T (1997) Na+/H+-exchanger 3 activity and its gene in the spontaneously hypertensive rat kidney. J Hypertens 15: 43–48.[Medline]

Hirata K, Kikuchi A, Sasaki T, Kuroda S, Kaibuchi K, Matsuura Y, Seki H, Saida K, and Takai Y (1992) Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. J Biol Chem 267: 8719–8722.[Abstract/Free Full Text]

Kaplan N (1998) Primary hypertension: pathogenesis, in Clinical Hypertension, pp 41–100, Williams & Wilkins, Baltimore.

Kawaguchi A, Ohmori M, Harada K, Tsuruoka S, Sugimoto K, and Fujimura A (2000) The effect of a Rho kinase inhibitor Y-27632 on superoxide production, aggregation and adhesion in human polymorphonuclear leukocytes. Eur J Pharmacol 403: 203–208.[CrossRef][Medline]

Kawaguchi A, Sugimoto K, and Fujimura A (2001) Preventive effect of platelet-activating factor antagonist, Y-24180, against cyclosporine-induced acute nephro-toxicity. Life Sci 68: 1181–1190.[CrossRef][Medline]

Khraibi AA and Knox FG (1989) Effect of acute renal decapsulation on pressure natriuresis in SHR and WKY rats. Am J Physiol 257: F785–F789.

Kurashima K, D'Souza S, Szaszi K, Ramjeesingh R, Orlowski J, and Grinstein S (1999) The apical Na+/H+ exchanger isoform NHE3 is regulated by the actin cytoskeleton. J Biol Chem 274: 29843–29849.[Abstract/Free Full Text]

Mills JW, Schwiebert EM, and Stanton BA (1994) The cytoskeleton and membrane transport. Curr Opin Nephrol Hypertens 3: 529–534.[Medline]

Morduchowicz GA, Sheikh-Hamad D, Jo OD, Nord EP, Lee DB, and Yanagawa N (1989) Increased Na+/H+ antiport activity in the renal brush border membrane of SHR. Kidney Int 36: 576–581.[Medline]

Orlowski J, Kandasamy RA, and Shull GE (1992) Molecular cloning of putative members of the Na/H exchanger gene family. cDNA cloning, deduced amino acid sequence and mRNA tissue expression of the rat Na/H exchanger NHE-1 and two structurally related proteins. J Biol Chem 267: 9331–9339.[Abstract/Free Full Text]

Rose D (1994) Regulation of the effective circulating volume, in Clinical Physiology of Acid-Base and Electrolyte Disorders, pp 235–260, McGraw-HIll, Inc., New York.

Shrode LD, Klein JD, O'Neill WC, and Putnam RW (1995) Shrinkage-induced activation of Na+/H+ exchange in primary rat astrocytes: role of myosin light-chain kinase. Am J Physiol 269: C257–C266.

Szaszi K, Kurashima K, Kapus A, Paulsen A, Kaibuchi K, Grinstein S, and Orlowski J (2000) RhoA and rho kinase regulate the epithelial Na+/H+ exchanger NHE3. Role of myosin light chain phosphorylation. J Biol Chem 275: 28599–28606.[Abstract/Free Full Text]

Takeda M, Yoshitomi K, and Imai M (1993) Regulation of Na+-3HCO3- cotransport in rabbit proximal convoluted tubule via adenosine A1 receptor. Am J Physiol 265: F511–F519.

Thomas J, Buschsbaum R, Zimniak A, and Racker E (1979) Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectrometric probes generated in situ. Biochemistry 18: 2210–2218.[CrossRef][Medline]

Tsuruoka S and Schwartz GJ (1997) Metabolic acidosis stimulates H+ secretion in the rabbit outer medullary collecting duct (inner stripe) of the kidney. J Clin Investig 99: 1420–1431.[Medline]

Tsuruoka S, Sugimoto KI, Fujimura A, Imai M, Asano Y, and Muto S (2001) P-Glycoprotein-mediated drug secretion in mouse proximal tubule perfused in vitro. J Am Soc Nephrol 12: 177–181.[Abstract/Free Full Text]

Tsuruoka S, Sugimoto K, Muto S, Nomiyama K, Fujimura A, and Imai M (2000) Acute effect of cadmium-metallothionein on glucose and amino acid transport across the apical membrane of the rabbit proximal tubule perfused in vitro. J Pharmacol Exp Ther 292: 769–777.[Abstract/Free Full Text]

Tsuruoka S, Takeda M, Yoshitomi K, and Imai M (1993) Cellular heterogeneity of ammonium ion transport across the basolateral membrane of the hamster medullary thick ascending limb of Henle's loop. J Clin Investig 92: 1881–1888.

Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, and Narumiya S (1997) Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature (Lond) 389: 990–994.[CrossRef][Medline]

White GE and Fujiwara K (1986) Expression and intracellular distribution of stress fibers in aortic endothelium. J Cell Biol 103: 63–70.[Abstract/Free Full Text]

Yamori Y (1974) Importance of genetic factors in stroke: an evidence obtained by selective breeding of stroke-prone and -resistant SHR. Jpn Circ J 38: 1095–1100.[Medline]


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
X. Yang, H.-C. Huang, H. Yin, R. J. Alpern, and P. A. Preisig
RhoA required for acid-induced stress fiber formation and trafficking and activation of NHE3
Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1054 - F1064.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Winaver, E. Ovcharenko, I. Rubinstein, K. Gurbanov, P. Pollesello, B. Bishara, A. Hoffman, and Z. Abassi
Involvement of Rho kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H2007 - H2014.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. T. Sylvester
The tone of pulmonary smooth muscle: ROK and Rho music?
Am J Physiol Lung Cell Mol Physiol, October 1, 2004; 287(4): L624 - L630.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishiki, K.
Right arrow Articles by Fujimura, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishiki, K.
Right arrow Articles by Fujimura, A.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition